SC 13G/A | 2024-02-14 | ARMISTICE CAPITAL, LLC | ENANTA PHARMACEUTICALS INC | 2,064,000 | 9.8% | EDGAR |
SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | ENANTA PHARMACEUTICALS INC | 1,793,786 | 8.5% | EDGAR |
SC 13G/A | 2024-01-26 | Farallon Capital Partners, L.P. | ENANTA PHARMACEUTICALS INC | 379,200 | 1.8% | EDGAR |
SC 13G/A | 2024-01-24 | BlackRock Inc. | ENANTA PHARMACEUTICALS INC | 1,934,711 | 9.2% | EDGAR |
SC 13G/A | 2024-01-22 | STATE STREET CORP | ENANTA PHARMACEUTICALS INC | - | 2.0% | EDGAR |
SC 13G | 2024-01-11 | MILLENNIUM MANAGEMENT LLC | ENANTA PHARMACEUTICALS INC | 1,314,949 | 6.2% | EDGAR |
SC 13G | 2023-11-16 | MILLENNIUM MANAGEMENT LLC | ENANTA PHARMACEUTICALS INC | 1,024,676 | 4.9% | EDGAR |
SC 13G/A | 2023-10-06 | BlackRock Inc. | ENANTA PHARMACEUTICALS INC | 1,978,011 | 9.4% | EDGAR |
SC 13G/A | 2023-02-14 | FIRST MANHATTAN CO | ENANTA PHARMACEUTICALS INC | 243,718 | 1.2% | EDGAR |
SC 13G | 2023-02-14 | ARMISTICE CAPITAL, LLC | ENANTA PHARMACEUTICALS INC | 2,078,000 | 10.0% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | ENANTA PHARMACEUTICALS INC | 1,522,189 | 7.3% | EDGAR |
SC 13G/A | 2023-02-08 | STATE STREET CORP | ENANTA PHARMACEUTICALS INC | - | 7.3% | EDGAR |
SC 13G/A | 2023-02-06 | Farallon Capital Partners, L.P. | ENANTA PHARMACEUTICALS INC | 281,900 | 1.4% | EDGAR |
SC 13G | 2023-01-31 | BlackRock Inc. | ENANTA PHARMACEUTICALS INC | 3,753,075 | 18.0% | EDGAR |
SC 13G/A | 2022-02-15 | ARMISTICE CAPITAL, LLC | ENANTA PHARMACEUTICALS INC | 1,056,000 | 5.1% | EDGAR |
SC 13G | 2022-02-15 | FIRST MANHATTAN CO | ENANTA PHARMACEUTICALS INC | 1,108,836 | 5.5% | EDGAR |
SC 13G/A | 2022-02-14 | ARMISTICE CAPITAL, LLC | ENANTA PHARMACEUTICALS INC | 1,056,000 | 5.1% | EDGAR |
SC 13G/A | 2022-02-11 | STATE STREET CORP | ENANTA PHARMACEUTICALS INC | - | 5.6% | EDGAR |
SC 13G/A | 2022-02-11 | FARALLON CAPITAL MANAGEMENT LLC | ENANTA PHARMACEUTICALS INC | 287,000 | 1.4% | EDGAR |
SC 13G/A | 2022-02-10 | RENAISSANCE TECHNOLOGIES LLC | ENANTA PHARMACEUTICALS INC | 714,400 | 3.5% | EDGAR |